Page tree

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

#

Code

Term

Status

Content team evaluation

Products that use this form

Expert feedback

Action / Plan

113179000Granules for modified-release oral suspensionNot Referenced761

Matt Cordell we have that form in AMT "modified release granules".
It's used for mesalazine and morphine products. (11 Clinical drug concepts). And 1 para-aminosalicylic acid.


213184000Powder for solution for provocation testNot ReferencedNot in scope

Julie M. James has too much specificity about the use, which is out of scope for SNOMED PDF

Rutt Lindström Maybe it is worth mapping to a broader SNOMED dose form?

Stuart Abbott IMprove scope definition to have a clear explanation on how too much detail may put the code out of scope

Evaluate a narrow to broader map
313168000Oromucosal drops, solutionNot ReferencedIn scope
Julie M. James We have 385072008 | Conventional release oromucosal drops (dose form) | but not the more detailed dose forms.  Following the principles and pattern we now have for other types of drops etc. (e.g. 385125006 | Conventional release solution for eye drops (dose form) ), this concept should be added to SNOMED CT if/when required to support description of productsAdd if/when required
413169000Oromucosal drops, suspensionNot Referenced

As above (row 3)Add if/when required
513177000Granules for gastro-resistant oral suspensionNot Referenced

761901008 | Granules for gastro-resistant oral suspension (dose form) |

Make new map

MJO - mapped.

613165000Suspension for gelNot Referenced

Julie M. James Could be added to SCT if required as Suspension for conventional release cutaneous gel. 
BDF = suspension, Int Site = Cutaneous AdmMeth = Apply Rel Char = Conventional Transform = Mix

Add if/when required
713178000Powder for gastro-resistant oral suspensionNot ReferencedIn scope

Julie M. James We (SCT) have a differentiation between powders and granules when the dose form is for oral use (but not for parenteral use), so could add this dose form to make the map if required; it fits the model

Add if/when required
813162000Concentrate for cutaneous emulsionNot Referenced

1237287002 | Concentrate for conventional release cutaneous solution (dose form) |

Make new map

MJO - mapped

913180000Granules for prolonged-release oral suspensionNot ReferencedIn scope
421446006 | Granules for prolonged-release oral suspension (dose form) |

Make new map

MJO - mapped

1013159000Eye drops, prolonged-release solutionNot Referenced

1279737007 | Prolonged-release solution for eye drops (dose form) |

Make new map

MJO - mapped

1113175000Prolonged-release chewable tabletNot ReferencedIn scope
Feedback from EDQM: This is a correct dose form; the tablet is chewed and breaks up into pieces that are swallowed.  These pieces have a formulation that gives the prolonged release characteristics, therefore this is a valid dose form and could be added to S-CT if/when requiredAdd if/when required
1213176000Powder for prolonged-release oral suspensionNot ReferencedIn scope
As above (row 7)Add if/when required
1313167000Oromucosal drops, emulsionNot Referenced

As above (row 3)Add if/when required
1419186000Implantation gelNot Referenced

Julie M. James Complex!  Is final administrable dose form when the two concepts below are mixed.....


1513187000Dispersion for implantation gelNot Referenced



1613188000Solution for implantation gelNot Referenced



1713190000Intracameral implantNot Referenced

Julie M. James We have 762071007 | Intraocular dose form (dose form) | and 3 children, then separately we have 764842006 | Prolonged-release ocular implant (dose form) | which is not mapped to EDQM (I think).  I suggest that we may wish to add these as children of the "intraocular" grouper
Does anybody know of an "ocular implant2 (not insert) that is "ocular" not "intraocular"?
Ocular - the eyeball - on or in; intraocular - "within" the eyeball

NI: Intracameral implant and Intravitreal implant added as directed
1813191000Intravitreal implantNot Referenced

Julie M. James As for intracameral


...